MENU
AGEN
AS OF
Dec 12 closing price
Price
$3.79
Change
-$0.29 (-7.11%)
Capitalization
128.89M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agenus (AGEN) Ownership - Who owns Agenus?

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body’s immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
128.89M
P/E Ratio
0.16
Total Cash
3.46M
Projected Growth
N/A
Total Debt
45.77M
Revenue
106.83M
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
14.79
Revenue/Share
3.97 USD as % of share price

Fundamentals

AGEN
Capitalization
129M
P/E Ratio
0.16
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash
3.46M
Total Cash/Share
0.10
Total Debt
45.8M
Total Debt/Equity
14.79
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.97%
Revenue
107M
ROE
N/A
Book Value
-274.14M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
329K
Current Ratio
0.47
Current Revenue Per Employee
95680.38
Dividends Per Share - Security
N/A
EBITDA
33.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
19.83
Revenue To Assets
-14.98
Shares Held By Institutions
80.5M
Shares Outstanding - Current
34M
Total Liabilities
515M
Total Volume MTD
N/A
Value
-1
Gain YTD
48.905
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+8%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
AGEN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for AGEN
A.I. Advisor
published General Information

General Information

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com